SCN8A p.Ser845Pro
c.2533T>C · rs1057518356 · VCV373333
ClinGen expert panel — Epilepsy Sodium Channel VCEP
Likely Pathogenic for complex neurodevelopmental disorder. Applied ACMG criteria (verbatim):
PP3_Moderate PM2_Supporting PM5_Supporting PM1
Curation rationale (ClinGen, verbatim)
The NM_001330260.2:c.2533T>C variant in SCN8A is a missense variant predicted to cause substitution of serine by proline at amino acid 845 (p.Ser845Pro). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.960, which is above the threshold of 0.773, evidence that correlates with impact to SCN8A function (PP3_Moderate). Another missense variant (c.2534C>T (p.Ser845Phe), ClinVar Variation ID: 207109) in the same codon has been classified as likely pathogenic for autosomal dominant complex neurodevelopmental disorder by the ClinGen Epilepsy Sodium Channel VCEP (PM5_Supporting). This variant resides within a region, amino acids 844-852, of SCN8A that is defined as a mutational hotspot and/or critical functional domain by the ClinGen Epilepsy Sodium Channel VCEP (PM1). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant complex neurodevelopmental disorder based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: PM1, PP3_Moderate, PM2_Supporting, PM5_Supporting. (VCEP specifications version 2.0.0; approved 8/26/25).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.975 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.96 | strongly pathogenic-leaning |
| SaProt | LLR -10.41 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.21 | constrained · MANE · 17 kb · p 8.5e-44 · regional, not allelic |
| Overall | ||
| CADD | 27.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- SCN8A
- Protein
- p.Ser845Pro
- Coding
- c.2533T>C
- MANE Select
- NM_001330260
- dbSNP
- rs1057518356
- Type
- single nucleotide variant
- Location
- chr12:51762665 (GRCh38)
- Gene constraint
- LOEUF 0.189 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 68.90 · 7 PDB
Disease context
complex neurodevelopmental disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Non-specific syndromic intellectual disability (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Childhood, Infancy
Similar variants
- SCN8A p.Ser845Cys Likely pathogenic ★★★ ⚠ same residue
- SCN8A p.Ser845Phe Likely pathogenic ★★★ ⚠ same residue
- SCN8A c.615-1G>A Pathogenic ★★★ same condition
- SCN8A p.Arg1872Gln Pathogenic ★★★ ⚠ same condition
- SCN8A p.Asn1318Ser Likely pathogenic ★★★ same condition
- SCN8A p.Asn418Asp Likely pathogenic ★★★ same condition
- SCN8A p.Glu1218Lys Pathogenic ★★★ same condition
- SCN8A p.Ile1631Thr Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scn8a-p-ser845pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown